Literature DB >> 11278584

Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-l-phenylalanyl chloromethyl ketone.

B A Ballif1, A Shimamura, E Pae, J Blenis.   

Abstract

The anti-tumorigenic and anti-proliferative effects of N-alpha-tosyl-l-phenylalanyl chloromethyl ketone (TPCK) have been known for more than three decades. Yet little is known about the discrete cellular targets of TPCK controlling these effects. Previous work from our laboratory showed TPCK, like the immunosuppressant rapamycin, to be a potent inhibitor of the 70-kilodalton ribosomal S6 kinase 1 (S6K1), which mediates events involved in cell growth and proliferation. We show here that rapamycin and TPCK display distinct inhibitory mechanisms on S6K1 as a rapamycin-resistant form of S6K1 was TPCK-sensitive. Additionally, we show that TPCK inhibited the activation of the related kinase and proto-oncogene Akt. Upstream regulators of S6K1 and Akt include phosphoinositide 3-kinase (PI 3-K) and 3-phosphoinositide-dependent kinase 1 (PDK1). Whereas TPCK had no effect on either mitogen-regulated PI 3-K activity or total cellular PDK1 activity, TPCK prevented phosphorylation of the PDK1 regulatory sites in S6K1 and Akt. Furthermore, whereas both PDK1 and the mitogen-activated protein kinase (MAPK) are required for full activation of the 90-kilodalton ribosomal S6 kinase (RSK), TPCK inhibited RSK activation without inhibiting MAPK activation. Consistent with the capacity of RSK and Akt to mediate a cell survival signal, in part through phosphorylation of the pro-apoptotic protein BAD, TPCK reduced BAD phosphorylation and led to cell death in interleukin-3-dependent 32D cells. Finally, in agreement with results seen in embryonic stem cells lacking PDK1, protein kinase A activation was not inhibited by TPCK showing TPCK specificity for mitogen-regulated PDK1 signaling. TPCK inhibition of PDK1 signaling thus disables central kinase cascades governing diverse cellular processes including proliferation and survival and provides an explanation for its striking biological effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278584     DOI: 10.1074/jbc.M009939200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Stimulation of FasL induces production of proinflammatory mediators through activation of mitogen-activated protein kinases and nuclear factor-κB in THP-1 cells.

Authors:  Sang-Min Lee; Eun-Ju Kim; Kyoungho Suk; Won-Ha Lee
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation.

Authors:  Maggaly Gillibert; Zakia Dehry; Micheline Terrier; Jamel El Benna; Florence Lederer
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

4.  A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development.

Authors:  Xiuning Le; Emily K Pugach; Simone Hettmer; Narie Y Storer; Jianing Liu; Airon A Wills; Antony DiBiase; Eleanor Y Chen; Myron S Ignatius; Kenneth D Poss; Amy J Wagers; David M Langenau; Leonard I Zon
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

5.  Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques.

Authors:  Won-Jung Kim; Eun-Mi Bae; Yoon-Joong Kang; Hyung-Uk Bae; Su Hyung Hong; Joo Y Lee; Jeong-Euy Park; Byoung S Kwon; Kyoungho Suk; Won-Ha Lee
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

6.  Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer.

Authors:  Xiaoli Li; Rui Lin; Jiansheng Li
Journal:  Dig Dis Sci       Date:  2011-04-30       Impact factor: 3.199

7.  Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

Authors:  Hongbing Zhang; Gregor Cicchetti; Hiroaki Onda; Henry B Koon; Kirsten Asrican; Natalia Bajraszewski; Francisca Vazquez; Christopher L Carpenter; David J Kwiatkowski
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  TPCK inhibits AGC kinases by direct activation loop adduction at phenylalanine-directed cysteine residues.

Authors:  Rana Anjum; Eunice Pae; John Blenis; Bryan A Ballif
Journal:  FEBS Lett       Date:  2012-08-10       Impact factor: 4.124

9.  Regulation of autophagy by α1-antitrypsin: "a foe of a foe is a friend".

Authors:  Michal G Shapira; Boris Khalfin; Eli C Lewis; Abraham H Parola; Ilana Nathan
Journal:  Mol Med       Date:  2014-10-27       Impact factor: 6.354

10.  N(alpha)-tosyl-L-phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1.

Authors:  Siriporn Jitkaew; Alicja Trebinska; Ewa Grzybowska; Göran Carlsson; Anders Nordström; Janne Lehtiö; Anne-Sophie Fröjmark; Niklas Dahl; Bengt Fadeel
Journal:  J Biol Chem       Date:  2009-08-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.